Abstract
2 Maternal and neonate outcomes following exposure to hyaluronidase-facilitated subcutaneous immunoglobulin 10% during pregnancy: a retrospective case series based on US claims data
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
